Harjai K J, Licata A A
Alton Ochsner Medical Foundation, New Orleans, Louisiana, USA.
Ann Intern Med. 1997 Jan 1;126(1):63-73. doi: 10.7326/0003-4819-126-1-199701010-00009.
To review the literature on the effects of amiodarone on thyroid physiology and management of amiodarone-induced thyroid disease.
English-language articles identified through a MEDLINE search (for 1975 to 1995, using the terms amiodarone and thyroid) and selected cross-referenced articles.
Articles on the effects of amiodarone on thyroid physiology and function tests and occurrence, recognition, and management of amiodarone-induced thyroid disease.
Data were manually extracted from selected studies and reports; emphasis was placed on information relevant to the practicing clinician.
Amiodarone can have many effects on thyroid function test results, even in the absence of hyperthyroidism or hypothyroidism. It may cause an increase in serum levels of thyroxine, reverse triiodothyronine, and thyroid-stimulating hormone and a decrease in serum triiodothyronine levels. Thyrotoxicosis occurs in some patients and is related to several pathogenetic mechanisms. It often present dramatically with obvious clinical manifestations and further changes in thyroid function test results. Medical options include therapy with thionamides, perchlorate, and prednisone. Radioactive iodine is of little use. Thyroidectomy is effective and is the only measure that consistently allows continued use of amiodarone. Unlike thyrotoxicosis, hypothyroidism is related to a persistent Wolff-Chaikoff effect and often has a vague presentation. The goal of treatment of amiodarone-induced hypothyroidism is to bring serum thyroxine levels to the upper end of the normal range, as often seen in euthyroid patients who are receiving amiodarone.
Thyroid dysfunction commonly occurs with amiodarone therapy. It may be difficult to recognize the dysfunction because of the many changes in thyroid function test results that occur in euthyroid patients who are receiving amiodarone. Effective strategies exist for the management of hyperthyroidism and hypothyroidism; these should be tailored to the needs of the individual patient.
综述有关胺碘酮对甲状腺生理的影响以及胺碘酮所致甲状腺疾病的处理的文献。
通过医学文献数据库(MEDLINE)检索(1975年至1995年,使用胺碘酮和甲状腺等检索词)确定的英文文章以及选定的交叉引用文章。
关于胺碘酮对甲状腺生理、功能测试以及胺碘酮所致甲状腺疾病的发生、识别和处理的文章。
从选定的研究和报告中手动提取资料;重点关注与临床执业医师相关的信息。
胺碘酮可对甲状腺功能测试结果产生多种影响,即使在无甲状腺功能亢进或减退的情况下也是如此。它可能导致血清甲状腺素、反三碘甲状腺原氨酸和促甲状腺激素水平升高,血清三碘甲状腺原氨酸水平降低。一些患者会发生甲状腺毒症,这与多种发病机制有关。其临床表现通常较为显著,伴有明显的临床症状以及甲状腺功能测试结果的进一步变化。药物治疗选择包括硫代酰胺、高氯酸盐和泼尼松治疗。放射性碘治疗效果不佳。甲状腺切除术有效,是唯一能始终允许继续使用胺碘酮的措施。与甲状腺毒症不同,甲状腺功能减退与持续的Wolff-Chaikoff效应有关,且通常表现不明显。胺碘酮所致甲状腺功能减退的治疗目标是使血清甲状腺素水平达到正常范围的上限,这在接受胺碘酮治疗的甲状腺功能正常患者中较为常见。
胺碘酮治疗时常见甲状腺功能障碍。由于接受胺碘酮治疗的甲状腺功能正常患者的甲状腺功能测试结果有多种变化,可能难以识别这种功能障碍。存在针对甲状腺功能亢进和减退的有效管理策略;这些策略应根据个体患者的需求进行调整。